A PHASE IIIB, MULTINATIONAL, MULTICENTER, OPEN-LABEL EXTENSION STUDY ASSESSING THE LONG-TERM SAFETY OF PRN INTRAVITREAL INJECTIONS OF DE-109 IN SUBJECTS WITH NON-INFECTIOUS UVEITIS OF THE POSTERIOR SEGMENT OF THE EYE WHO HAVE PARTICIPATED IN THE SAKURA DEVELOPMENT PROGRAM: